Leveraging gold-standard PCR technology, the cobas liat system claims to deliver outcomes in under 20 minutes.

A recent study finds that the risk for myalgic encephalomyelitis/chronic fatigue syndrome is increased following COVID-19.

The proof-of-concept demonstrates the power of pairing AI with lab orchestration solutions to automate molecular screening ...

Investigators from Mass General Brigham have found that a method originally designed for cancer detection can also identify ...

Any lingering doubts over the feasibility of rolling out population-based cancer registries in low-income and middle-income countries ought to have been dispelled by the COVID-19 pandemic. Within ...

Discover how the severity of Pediatric Inflammatory Multisystem Syndrome (PIMS-TS) evolved during successive COVID-19 waves, ...

Investigators from Mass General Brigham have found that a method originally designed for cancer detection can also identify and monitor even tiny amounts of SARS-CoV-2 intact viral particles in blood ...

Investigators from Mass General Brigham have found that a method originally designed for cancer detection can also identify ...

There certainly are good viruses, say our readers - who also paint a gloomy picture of what would happen if all viruses disappeared ...

Three days before Trump’s swearing in to office, the US Department of Health and Human Services announced that EcoHealth ...

(RTTNews) - AIM ImmunoTech Inc. (AIM), Wednesday revealed 15 times increase in incidence of Myalgic encephalomyelitis or ME/ Chronic Fatigue Syndrome or CFS in patients infected with SARS-CoV-2.